BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,605,031 | +4.6% | 791,671 | +4.0% | 1.70% | +2.5% |
Q2 2023 | $5,356,764 | +11.2% | 760,904 | +31.7% | 1.66% | -16.7% |
Q1 2023 | $4,818,493 | +54.2% | 577,757 | +112.3% | 1.99% | +122.5% |
Q4 2022 | $3,124,546 | +32.9% | 272,173 | +45.9% | 0.89% | +12.5% |
Q3 2022 | $2,351,000 | +315.4% | 186,603 | +248.7% | 0.80% | +356.9% |
Q2 2022 | $566,000 | +187.3% | 53,521 | -47.7% | 0.17% | +112.2% |
Q1 2022 | $197,000 | -76.0% | 102,425 | -6.9% | 0.08% | -82.8% |
Q4 2020 | $820,000 | – | 110,000 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |